Structure, assembly and homeostatic regulation of the 26S proteasome.
about
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's diseaseTRIM21: a cytosolic Fc receptor with broad antibody isotype specificityModulatory effects of bortezomib on host immune cell functionsDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentOrganizing principles of mammalian nonsense-mediated mRNA decayProteasome inhibition is partially effective in attenuating pre-existing immunity against recombinant adeno-associated viral vectorsPhosphatase UBLCP1 controls proteasome assemblyThe N-end rule pathway and regulation by proteolysisProfiling human protein degradome delineates cellular responses to proteasomal inhibition and reveals a feedback mechanism in regulating proteasome homeostasis.Molecular characterization and expressional affirmation of the beta proteasome subunit cluster in rock bream immune defense.Oxidative stress-mediated regulation of proteasome complexesA variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.Ubiquitination and proteolysis in acute lung injuryAAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome.Nuclear import factor Srp1 and its associated protein Sts1 couple ribosome-bound nascent polypeptides to proteasomes for cotranslational degradation.Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury.Protein Quality Control by Molecular Chaperones in Neurodegeneration.Protein kinase cδ in apoptosis: a brief overview.Development of Proteasome Inhibitors as Therapeutic Drugs.Assembly of the 20S proteasome.The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?Melatonin and ubiquitin: what's the connection?Effective delivery of a rationally designed intracellular peptide drug with gold nanoparticle-peptide hybrids.Modulation of proteasome machinery by natural and synthetic analogues of the marine bioactive compound petrosaspongiolide M.Inhibitor mediated protein degradation.Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer.Proteasome dysregulation in human cancer: implications for clinical therapies.O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1
P2860
Q26749321-46F8FD04-5901-43E3-9E38-143CD58453CDQ26779753-68E2E4DE-0E48-4256-ABCF-73F19CD22E95Q26795618-F6D58B31-1FA7-4CDC-8C92-7BEA09FB06CDQ27025321-5610FED0-90DF-49B3-8102-CE3FAD0EC5A5Q28302705-96A8412D-E465-4E80-87C1-A6E00037E9FFQ28730577-0451F642-8E95-4FB3-81ED-9B1A00CA7F7EQ33747496-A7CA09E1-8D01-4918-9D64-DAAA94C4F5E3Q34189152-3BD595C6-3AEF-49EA-A675-2A8DCC1821C4Q34289909-D74FA26A-8E8F-42AF-AF38-A70CFB09F610Q34421574-4CE986F6-D51D-4DEF-80F4-7FA90FC98D51Q34994401-783586FD-2741-4A4C-8FCC-CF1BF2BFD408Q35664025-E6A59383-5F9C-43BD-AE5E-01DB51D156B6Q35811448-3FB16FC4-8D0E-45F9-857C-8D9C766A5A30Q36438451-6BC6EECE-6577-4943-B18E-A39DE4BDF018Q37067213-B4C3942D-FA45-4DDE-B458-564772B5FF00Q37377197-BA6F4803-A756-4879-AE40-60961D892D6DQ37536502-7AF78C8D-7E57-4796-BECB-9A5C51159538Q37663375-EE799368-C27D-46B3-A824-4D5DF4F8F394Q37739093-6C2617B0-ABA5-44CD-BD7A-3B6C2D2D6607Q38037338-064E3436-92AE-4220-A93D-C863C8CB92EBQ38075795-A8F63DE7-A042-4670-9E29-C043E625A951Q38090856-8F941369-4957-4C51-905E-A86FD0F75E43Q38188569-AAD76512-E88B-4932-A43A-E778EB9EFD47Q38219604-7FF393D2-8D04-45FE-981F-0DFFA8567853Q38855835-93C8F56D-405D-4C7B-9DE2-7824DAC3E045Q39375693-0A7D3181-12BA-4C0A-B57E-096D014ADDA2Q42178606-B411D0C1-E266-43D1-AB60-4F9DA7F6D449Q47605422-A3755C94-3DCA-4670-BA5A-93008F324CD8Q50077966-6B5B7CE0-2C8F-4C37-9A5C-CDC35875EA3DQ58778244-91AA8532-79E0-4019-B932-8CD27FB29E05
P2860
Structure, assembly and homeostatic regulation of the 26S proteasome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Structure, assembly and homeostatic regulation of the 26S proteasome.
@en
Structure, assembly and homeostatic regulation of the 26S proteasome.
@nl
type
label
Structure, assembly and homeostatic regulation of the 26S proteasome.
@en
Structure, assembly and homeostatic regulation of the 26S proteasome.
@nl
prefLabel
Structure, assembly and homeostatic regulation of the 26S proteasome.
@en
Structure, assembly and homeostatic regulation of the 26S proteasome.
@nl
P356
P1476
Structure, assembly and homeostatic regulation of the 26S proteasome.
@en
P2093
Youming Xie
P304
P356
10.1093/JMCB/MJQ030
P577
2010-10-07T00:00:00Z